Market Place
Sourcing Support
Repare Therapeutics Partners with NCI to Develop Camonsertib
12 Nov 2024 //
BUSINESSWIRE
GlycoMimetics Uproleselan Study Did Not Meet Primary Endpoint
29 Oct 2024 //
BUSINESSWIRE
US FDA Issues Study May Proceed Letter For Pidnarulex
14 Oct 2024 //
PR NEWSWIRE
SciTech Development Receives Drug Supply From National Cancer Institute (NCI)
17 Sep 2024 //
PR NEWSWIRE
Biosplice Initiates NCI-Sponsored AML And MDS Trial
12 Sep 2024 //
GLOBENEWSWIRE
Qurient, NCI Collaborate On Q901 Plus TROP2-ADC Phase 1/2 Study
21 May 2024 //
BUSINESSWIRE
XBiotech Announces ANSM Approval, INSA funding for PII/III Study for Natrunix
28 Apr 2022 //
GLOBENEWSWIRE
NextCure and NCI Announce Preclinical Data in Journal of Clinical Investigation
19 Apr 2022 //
GLOBENEWSWIRE
Ankyra inks NCI pact to support cancer pipeline progress
19 Apr 2022 //
FIERCEBIOTECH
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.